Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Paul Allen Sutton is active.

Publication


Featured researches published by Paul Allen Sutton.


Drug Development and Industrial Pharmacy | 2012

Chemical interactions between an active pharmaceutical ingredient and its counterion in a tromethamine salt under forced degradation conditions

Eric Loeser; Paul Allen Sutton; Ada Skorodinsky; Melissa Lin; Guy Yowell

In this study, the tromethamine salt of an active pharmaceutical ingredient containing both a carboxylic acid and ethyl ester functionality was subjected to forced degradation conditions. Based on HPLC-MS analysis, it was found that tromethamine formed both amide and ester type condensation products with the API, with amide formation predominating over ester formation. Addition of tromethamine at the carboxylic acid group of the API was favored over addition at the ethyl ester group. Tromethamine condensation products were observed only under the harshest stress conditions (80 degrees and 75% relative humidity), in which the salt physically changed from a crystalline form to a deliquesced state. Under stress conditions in which the crystalline structure of the salt remained intact, good stability was observed. Thus, the interaction between tromethamine and API occurred only in cases where the crystallinity of the salt was compromised.


Archive | 2006

Pharmaceutical combinations of an angiotensin receptor antagonist and an nep inhibitor

Lili Feng; Sven Erik Godtfredsen; Piotr H. Karpinski; Paul Allen Sutton; Mahavir Prashad; Michael J. Girgis; Bin Hu; Yugang Liu; Thomas J. Blacklock


Tetrahedron Letters | 2012

LCZ696: a dual-acting sodium supramolecular complex

Lili Feng; Piotr H. Karpinski; Paul Allen Sutton; Yugang Liu; David Hook; Bin Hu; Thomas J. Blacklock; Philip E. Fanwick; Mahavir Prashad; Sven Erik Godtfredsen; Christoph Ziltener


Archive | 2003

Crystal forms of n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine

Paul Allen Sutton


Archive | 2006

Crystalline Forms of 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide

Paul W. Manley; Wen-Chung Shieh; Paul Allen Sutton; Piotr H. Karpinski; Raeann Wu; Stephanie Monnier; Jörg Brozio


Archive | 2006

Salts of 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide

Paul W. Manley; Wen-Chung Shieh; Paul Allen Sutton; Piotr H. Karpinski; Raeann Wu; Stephanie Monnier; Joerg Brozio


Archive | 2003

Salts of nateglinide

Paul Allen Sutton; Richard Victor Vivilecchia; David John Parker; Marilyn De. La. Cruz


Archive | 2006

Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl)-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cations

Lili Feng; Sven Erik Godtfredsen; Bin Hu; Yugang Liu; Piotr H. Karpinski; Paul Allen Sutton; Mahavir Prashad; Michael J. Girgis; Thomas J. Blacklock


Organic Process Research & Development | 2010

Process Research and Development of a MTP Inhibitor: Another Case of Disappearing Polymorphs upon Scale-up

Mahavir Prashad; Paul Allen Sutton; Raeann Wu; Bin Hu; James Vivelo; Joseph Carosi; Prasad Koteswara Kapa; Jessica Liang


Thermochimica Acta | 2005

The use of thermal desorption GC/MS to study weight loss in thermogravimetric analysis of di-acid salts

Changkang Pan; Frances Liu; Paul Allen Sutton; Richard Victor Vivilecchia

Collaboration


Dive into the Paul Allen Sutton's collaboration.

Researchain Logo
Decentralizing Knowledge